Text this: ROLE OF COMBINED 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF PATIENTS WITH DIFFERENTIATED THYROID CANCER